Intracardiac Thrombus
An intracardiac thrombus is a blood clot that forms inside one of the heart's chambers, which can disrupt normal blood flow and lead to serious health issues such as stroke or heart attack.
Anticoagulant Treatments for Intra-Cardiac Thrombus: The ARGONAUT Trial
We are comparing a new direct oral anticoagulant with a standard vitamin K antagonist in patients with intra-cardiac thrombus. The goal is to see which treatment better reduces complications and promotes thrombus regression.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Are you currently pregnant or breastfeeding?
- Have you had any major bleeding event in the last 6 months that required surgery or a blood transfusion?
- Do you have severe kidney disease (creatinine clearance less than 30 ml/min)?
- Do you have a known significant liver disease or liver enzyme levels (ALT) that are more than 3 times the normal limit?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Abagat
Abatixent
Abidalo
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Nimes
CARDIOLOGIE
Milhaud, France
Sponsor: Centre Hospitalier Universitaire De Nimes
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.